Physician profile
David Catalane
NPI 1326057399
$9,147.09
in general payments reported to CMS, 2019-2025
36 companies · $835 in 2025
The $835 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,427 · 2020: $629 · 2021: $855 · 2022: $1,017 · 2023: $2,284 · 2024: $1,100 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,293 · Travel and Lodging: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,292.59 |
| Travel and Lodging | $926.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,512.86 | 2021-2025 | Ellipsys Vascular Access System, Endurant Iis, Transorb |
| Cardiovascular Systems INC. | $1,475.74 | 2019-2022 | |
| Davol INC. | $1,192.23 | 2019-2023 | Phasix Mesh |
| Medtronic Vascular, INC. | $574.08 | 2019-2020 | |
| Silk Road Medical, INC. | $416.26 | 2019 | |
| Surmodics, INC. | $316.58 | 2024-2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Xl Thrombectomy |
| Inari Medical, INC. | $310.24 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $284.10 | 2023-2024 | Gore-Tex Vascular Graft, Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Philips North America LLC | $257.46 | 2021-2024 | (Br5) Peripheral Ivus |
| Smith+Nephew, INC. | $248.10 | 2019-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Abbott Laboratories | $234.93 | 2024 | Esprit, Jeti All In One Non-Sterile Kit |
| Tela Bio, INC. | $205.36 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $186.18 | 2022-2023 | Ethicon, Stratafix, Vistaseal |
| Penumbra, INC. | $122.45 | 2021 | |
| Boston Scientific Corporation | $113.03 | 2019-2025 | General - Vascular Access |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $92.60 | 2022 | |
| Aroa Biosurgery Incorporated | $77.61 | 2023-2025 | |
| Braintree Laboratories, INC. | $48.89 | 2020-2021 | |
| Organogenesis INC. | $46.52 | 2023-2024 | Puraply |
| Intuitive Surgical, INC. | $40.59 | 2019-2024 | |
| Atricure, INC. | $37.21 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Integra Lifesciences Corporation | $36.51 | 2020 | |
| Teleflex LLC | $36.16 | 2024-2025 | Deknatel, Quikclot |
| Vertex Pharmaceuticals Incorporated | $30.83 | 2025 | |
| Becton, Dickinson and Company | $30.19 | 2023 | Phasix Mesh, Ventralight St |
| Innocoll Pharmaceuticals Limited | $28.56 | 2021 | |
| Mallinckrodt Hospital Products INC. | $28.48 | 2020 | |
| Bioventus LLC | $25.54 | 2022 | |
| Lifenet Health | $23.27 | 2024-2025 | Theragenesis Wound Matrix |
| Acera Surgical, INC. | $20.80 | 2025 | Restrata Wound Matrix |
| Takeda Pharmaceuticals U.S.A., INC. | $18.62 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.46 | 2023 | Exparel |
| Thd America, INC. | $15.74 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.26 | 2020 | |
| Amgen INC. | $13.92 | 2023 | Prolia, Evenity |
| Cumberland Pharmaceuticals, INC. | $13.73 | 2023 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Catalane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.